Methicillin-resistant Staphylococcus aureus bloodstream infection surveillance: National healthcare safety network’s laboratory-identified event reporting versus traditional laboratory-confirmed bloodstream infection surveillance

Infection Control and Hospital Epidemiology

Volumn 35, Issue 10, 2014, Pages 1286-1289

  Baker, Arthur W ^a,b   Durkin, Michael J ^a,b   Dicks, Kristen V ^a,b   Lewis, Sarah S ^a,b   Moehring, Rebekah W ^a,b,c   Chen, Luke F ^a,b   Sexton, Daniel J ^a,b   Anderson, Deverick J ^a,b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b DUKE UNIVERSITY   (United States)

^c DURHAM VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BLOODSTREAM INFECTION; COMMUNITY ACQUIRED INFECTION; COMMUNITY HOSPITAL; COMPARATIVE STUDY; DISEASE SURVEILLANCE; HOSPITAL INFECTION; HUMAN; LABORATORY CONFIRMED BLOODSTREAM INFECTION REPORTING; LABORATORY IDENTIFIED EVENT REPORTING; MAJOR CLINICAL STUDY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; VOLUNTARY REPORTING; CROSS INFECTION; HEALTH SURVEY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIOLOGY; SEPSIS; STAPHYLOCOCCAL INFECTIONS; UNITED STATES;

CROSS INFECTION; HUMANS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; POPULATION SURVEILLANCE; SEPSIS; STAPHYLOCOCCAL INFECTIONS; UNITED STATES;

EID: 84907212488     PISSN: 0899823X     EISSN: 15596834     Source Type: Journal    
DOI: 10.1086/678071     Document Type: Article

References (6)

1. Centers for Disease Control and Prevention (CDC). Operational Guidance for Acute Care Hospitals to Report Facility-Wide Inpatient (FacWideIN) Methicillin-Resistant Staphylococcus aureus (MRSA) Blood Specimen (Bacteremia) Laboratory-Identified (LabID) Event Data to CDC’s NHSN for the Purpose of Fulfilling CMS’s Hospital Inpatient Quality Reporting (IQR) Requirements. Atlanta: CDC, 2012. http://www.cdc.gov/nhsn/PDFs/mrsa-cdi/FINAL-ACH-MRSA-Bacteremia-Guidance.pdf. Accessed January 13, 2014.
2. Centers for Disease Control and Prevention (CDC). Multidrug-Resistant Organism and Clostridium difficile Infection (MDRO/ CDI) Module. Atlanta: CDC, 2014. http://www.cdc.gov/nhsn/PDFs/pscManual/12pscMDRO_CDADcurrent.pdf. Accessed January 13, 2014.
3. Centers for Disease Control and Prevention (CDC). LabID Event FAQs. Atlanta: CDC, 2013. http://www.cdc.gov/nhsn/PDFs/faqs/psc/labID-PSC-FAQ-ver5-7.pdf. Accessed December 28, 2013.
4. Centers for Disease Control and Prevention (CDC). CDC/NHSN Surveillance Definitions for Specific Types of Infections. Atlanta: CDC, 2014. http://www.cdc.gov/nhsn/pdfs/pscmanual/17pscnosinfdef_current.pdf. Accessed January 13, 2014.
5. Anderson DJ, Miller BA, Chen LF, et al. The network approach for prevention of healthcare-associated infections: long-term effect of participation in the Duke Infection Control Outreach Network. Infect Control Hosp Epidemiol 2011;32(4):315–322.
6. Chihara S, Popovich KJ, Weinstein RA, Hota B. Staphylococcus aureus bacteriuria as a prognosticator for outcome of Staphylococcus aureus bacteremia: a case-control study. BMC Infect Dis 2010;10:225.